Abstract
Introduction
The pain processing (nociception) system was historically conceptualised as a "hard-wired" pain pathway which reproduces a pain sensation in direct proportion to the extent and severity of the painful (noxious) insult. However, this concept was challenged from the 1940's and the gate-control theory of pain mechanisms published by Melzack and Wall in 1965, had a profound influence in the field of pain research and in the development of various forms of pain therapy. 1 This theory integrates the views of neurophysiology and psychology and states that spinal transmission of pain impulses is continuously modulated by the relative activity in the small (A-delta and C) fibres and the large (A-beta) fibres and by descending messages from the brain that originate in the cerebral cortex and brainstem. In subsequent years the theory has been criticised as an over-simplification and a series of "gates" at different levels of the spinal cord and in the higher centres have been postulated. The modern discipline of pain management was launched by the publication of the first edition of John F. Bonica's Management of Pain in 1953, 2 and he established the first interdisciplinary pain clinic in 1947 at the University of Washington in Seattle to treat the pain of war veterans.
Despite many advances over the past 50 years, poorly controlled pain remains a worldwide problem. According to a 1998 World Health Organization Survey of 26 000 primary care patients on five continents, 22% reported persistent pain over the past year. 3 Part of the problem lies with some health-care providers who have failed to keep up with the advances in pain medicine and continue to follow the biomedical approach, which regards a specific pathway as the only source of pain. In this model, all pain is regarded as a warning signal of tissue injury, and if conservative treatment fails, some surgical technique will be able to correct the problem. 4, 5 The modern paradigm of pain management has moved from this biomedical to the broader biopsychosocial approach, where pain mechanisms now integrate input from sensory, emotional and cognitive systems. 4, 6, 7 The current definition of pain as proposed by the IASP, reads: "Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage". 8 This definition identifies the complex and multi-dimensional experience of pain, where the patient's physical, cognitive, emotional and behavioural characteristics mediate the pain experience. 9 With acute pain of known cause, there may only be a minor contribution from the emotional and cognitive dimen- 4, 6, 7 sions -in patients with a chronic pain disorder for many years, these dimensions may play a major role in pain perception. 10 A multitude of brain regions (known as the "pain matrix") are activated following a pain stimulus. Rather than registering the pain signal to produce pain perception, the brain matrix constructs the pain experience by integrating multiple inputs, including biological (sensory) factors, present and past psychological events and socio-cultural influences.
Acute pain
Acute pain is a normal biological response to injury or tissue trauma and a signal of ongoing or impending tissue damage, e.g. post-operatively. It protects the organism from further injury and promotes healing after injury. Acute pain is a symptom that must be treated or its cause eliminated. 11, 12 Untreated acute pain may cause unnecessary suffering and increase morbidity, it may also lengthen the recovery time after tissue injury.
There is increasing recognition that long-term changes may occur within the peripheral and central nervous system following the noxious input of painful stimuli. Even brief intervals of untreated acute pain can induce longterm neuronal remodelling and central sensitization ("plasticity") and may lead to chronic pain in some patients. This "plasticity" of the nervous system then alters the body's response to further sensory input, it becomes more sensitive to pain impulses and even innocuous stimuli may then trigger pain perception. 1, 11, 12, 13 Central sensitization is a complex process involving many neurochemical and molecular processes, and is induced by the release of neuropeptides such as substance P and glutamate, which then activate the NMDA-receptor-complex. 2, 13, 14 The subsequent intra-cellular events may lead to long-term neuronal changes, characterized by a more sensitive nervous system and hyperalgesia. Acute post-operative pain may be followed by persistent pain in 10-40% of individuals, in particular after procedures such as inguinal hernia repair, thoracotomy, and breast surgery. 15 Central sensitization after tissue and nerve injury is also believed to be a mechanism for this phenomenon. Current data therefore support a comprehensive and multimodal approach to post-operative pain management. 16 Pain intensity should be assessed routinely, just as one monitors other vital signs, to ensure that acute pain is managed appropriately. 11, 12 Nociceptive pain (e.g. trauma, surgery) Nociceptive pain occurs when intact peripheral nerve endings (nociceptors) are stimulated by noxious stimuli that may be mechanical, thermal or chemical. Tissue damage generates release of peptides and other components of the inflammatory soup with eventual peripheral sensitization. Peripheral sensitization is one way in which the nociceptive system can be upregulated in response to tissue injury.
Primary types of pain

Neuropathic pain
While nociceptive pain is the result of stimulation of the nervous system, neuropathic pain is due to a lesion in the peripheral or central nervous system, e.g. in patients with diabetic or AIDS poly-neuropathy and post-herpetic neuralgia.
Dysfunctional pain
There is a large group of chronic pain patients where no peripheral abnormality or neurological deficit can be detected. The mechanism of pain is abnormal sensory processing of non-painful stimuli once the central nervous system has become sensitized. 11, 14, 17 These include the idiopathic pain disorders such as irritable bowel syndrome, chronic headaches, post-whiplash disorders, fibromyalgia syndrome and others. 18 Both neuropathic and dysfunctional pain may be present in the absence of an ongoing peripheral stimulus or "organic cause", and it is wrong to assume that these patients are only "psychological" or "hysterical". 11, 17, 18 Mixed pain These include patients with cancer pain and low back pain (in particular low back pain following surgery, or failed back surgery syndrome) where neuropathic, nociceptive and myofascial components may contribute to the patient's pain experience.
Chronic pain
The IASP has defined chronic pain as "pain that persists for longer than the time expected for healing, or pain associated with progressive, non-malignant disease", usually taken to be three months. 19 Chronic pain often persists long after the tissue trauma that has triggered its onset, has resolved and may be present in the absence of identified ongoing tissue damage. 20 Chronic pain is a dysfunctional response which mostly does not warn the individual of underlying disease or injury and has been widely acknowledged as a "disease in its own right". 21 Chronic pain may be associated with an underlying chronic disease such as arthritis. However, the largest group of chronic pain patients in the current epidemic in developed countries, comprises the chronic pain syndromes of unknown etiology. 12 These pain syndromes have no confirmatory laboratory evidence and are diagnosed on the basis of clinical criteria, e.g. the headache syndromes, irritable bowel syndrome, fibromyalgia and non-specific (or "simple") low back pain.
The tendency to consider chronic pain as either psychological or physical, implies a false dichotomy -both play a role in most chronic pain disorders, although the balance between organic pathology and psychosocial contributions may differ in different pain disorders. The emotional component of pain is complex and is influenced by past experiences, patient-beliefs and fears. 22, 23 Negative beliefs and an attitude of hopelessness may generate maladaptive illness behaviour with increased pain-reporting. 
CPD Article
Pain assessment 24, 25, 26, 27 Pain is a subjective, complex and personal phenomenon and can only be assessed indirectly by patient report. Methods used for acute pain screening are insufficient to provide a comprehensive view of the multidimensional impact of chronic pain on the patient. In a patient with chronic pain, assessment should not be limited to pain severity, but at least also include pain-related functional interference and the emotional impact of the pain. Uni-dimensional pain scales assess pain intensity and include numerical rating, visual analogue scales (VAS) and picture scales (facial expressions). Multidimensional pain scales assess the effect of pain on mood, activities and quality of life, and include the McGill Pain Questionnaire and the Brief Pain Inventory. A full clinical examination may provide clues to the causes of pain and formal psychological evaluation is indicated in a subset of chronic pain patients to assess them for maladaptive pain behaviour, somatoform disorder, etc.
Management of chronic pain syndromes
The biomedical approach has traditionally promised a cure by cutting or blocking the pain pathways pharmacologically or surgically. The biopsychosocial approach views pain as a dynamic interaction between physical, psychological and social factors, and more realistic treatment goals for patients include 28 :
• The reduction, mostly not elimination, of pain • Improvement in physical / social functioning • Improvement in mood and associated symptoms such as sleeping pattern • Development of active coping style and self-management-skills • A return to work • Reduction in utilization of medical services Evidence increasingly lends support to the use of an interdisciplinary approach where multiple therapies are provided in a co-ordinated manner, and where there is active interaction and a common philosophy that promotes active patient involvement, between participants. 28, 29 It is recommended that a core-team is involved in the primary care management of chronic pain patients. Its composition will differ from area to area, also depending on the availability of resources and the complexity of a patient's pain problem. A core-team may consist of a pain management physician (mostly a primary care doctor with a special interest in pain management) a physiotherapist and occupational therapist. Additional members of an interdisciplinary team in larger metropolitan areas may include, but are not limited to, an anaesthetist with interventional skills, a neurologist, an orthopaedic surgeon, a psychiatrist / psychologist, and a biokinetesist. The roles of team members may also overlap and the physiotherapist may also be responsible for education, an exercise programme and to assist in applying the principles of cognitive behavioural therapy. 28 It has been demonstrated that interdisciplinary management, which emphasizes functional restoration produces the best outcomes in the management of chronic pain patients. 
Physiotherapy, exercise and occupational therapy
The role of the physiotherapist is broad and includes education on pain mechanisms and self-management, goal-setting and a graded activity programme, pacing and helping patients to acquire problem-solving skills. 32 An important element in physical rehabilitation involves improvement in function through therapeutic exercises designed individually to increase functional activity.
Passive manual methods are deemphasized in modern physiotherapy and should be integrated in a more active and comprehensive programme. Physiotherapists who are too somatically focussed, e.g. on the "degenerated disc" may reinforce illness behaviour and perpetuate the problem. 32 The physiotherapist should be informed on the cognitive and behavioural components of pain presentation and assist in addressing inappropriate pain-behaviour.
Occupational therapists work closely with physiotherapists in activity planning and in assessing domestic and workplace circumstances. 32 Return to work, even in the presence of some degree of pain, is an important component of chronic pain management. 33, 34, 35 • The goal of pharmacotherapy should be to improve pain intensity and functioning while avoiding cognitive impairment and organ toxicity.
Principles of pharmacological therapy
• Many patients don't present with pure nociceptive or neuropathic pain, but rather have a mixed pain syndrome, therefore rational polypharmacy is often appropriate.
• The World Health Organization (WHO) analgesic three-step ladder for the rational use of analgesics in cancer pain, has also been applied for non-cancer pain for many years, in particular for nociceptive pain.
• There is a move away from this empirical approach in chronic pain pharmacotherapy, to an approach that is targeted at the particular pain mechanism responsible for the patient's pain (e.g. drugs that influence central sensitization).
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• For continuous analgesia consider long-acting medication on a regular basis, rather than "as needed".
• Analgesics are generally more effective for nociceptive pain, and less effective for neuropathic pain.
Non-opioid analgesics
Paracetamol is still recommended as first-line therapy for osteo-arthritis.
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Non-steroidal anti-inflammatory drugs (NSAIDs) may be combined with paracetamol or opioids. 
Opioid analgesics Weak opioids
Codeine phosphate is a very weak analgesic and has almost no analgesic effect by itself. Its role in chronic pain management is very limited (if any).
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The long-term use of polycomponent codeine combinations (containing caffeine, meprobamate and others) is strongly discouraged in chronic pain. Their potential for nephro-toxicity is greater and they are often associated with rebound pain.
Tramadol is an opioid of moderate strength and also inhibits nor-adrenaline and serotonin re-uptake from nerve endings. A number of studies have demonstrated the efficacy of tramadol in chronic pain conditions such as neuropathic pain, osteoarthritis, fibromyalgia and low back pain. It has a proven synergy with paracetamol, is not associated with peptic ulceration, renal dysfunction or cardiovascular side-effects and has a very low addictive potential.
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Strong opioids 37, 38, 39 Current evidence supports the use of strong opioids in a carefully selected subset of patients with chronic and resistant non-cancer pain. A detailed assessment should be performed by an experienced pain management physician before strong opioids are prescribed. Strong opioid treatment for chronic pain should not be considered life-long treatment and only sustained -release opioids, e.g. transdermal fentanyl and sustained release oral morphine, should be used. 28, 33, 40 Neuropathic pain is mostly treated with medications that influence neurotransmitters, e.g. antidepressants and antiepileptic drugs. Opioids are mostly reserved for patients with refractory neuropathic pain.
Adjuvant drugs
Antidepressants
• Tricyclic antidepressants (e.g. amitriptyline) are effective for neuropathic and non-neuropathic pain and its analgesic effect occurs at lower doses than its antidepressant effect. These drugs are associated with bothersome anti-cholinergic sideeffects and serious cardiovascular side-effects in older patients with established heart-disease.
• Selective serotonin re-uptake inhibitors (SSRIs) are predominantly serotonergic drugs and are mostly ineffective in treating chronic pain.
• Serotonin and norepinephrine reuptake inhibitors (SNRIs), e.g. duloxetine has proven efficacy in some patients with neuropathic pain and fibromyalgia (even in the absence of major depressive disorder). 
Anti-epileptic drugs
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Principles of behavioural therapy 22, 28, 31, 41, 42 Several behavioural approaches may lead to long-term reduction in pain intensity and improvement in physical and social functioning. In some chronic pain patients, the patient's belief about the pain and its effects is a better predictor of suffering and disability than the actual disease process and / or tissue damage. • Epidural steroid injections may provide temporary pain relief in patients with radicular low back pain.
• Pulsed radiofrequency is a non-destructive procedure that may relieve chronic neuropathic pain in selected patients -however, more evidence is needed before official recommendation for this procedure in guidelines will be appropriate. 
